ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

NVTA Invitae Corporation

0.0891
0.00 (0.00%)
After Hours
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Invitae Corporation NYSE:NVTA NYSE Common Stock
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.0891 0 01:00:00

Invitae to Announce Third Quarter 2016 Financial Results and Host Conference Call on November 7, 2016

24/10/2016 12:00pm

Business Wire


Invitae (NYSE:NVTA)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Invitae Charts.

Invitae Corporation (NYSE: NVTA), a genetic information company, today announced that it will report its third quarter 2016 financial results on Monday, November 7, 2016 and will host a conference call that day at 4:45 pm Eastern / 1:45 pm Pacific to discuss its financial results and recent developments.

The dial-in numbers for the conference call are (877) 201-0168 for domestic callers and (647) 788-4901 for international callers, and the reservation number for both is 5259406.

The live, listen-only webcast of the conference call may be accessed by visiting the investors section of the company’s website at ir.invitae.com. A replay of the webcast will be available shortly after the conclusion of the call and will be archived on the company’s website.

About Invitae

Invitae Corporation’s (NYSE: NVTA) mission is to bring comprehensive genetic information into mainstream medical practice to improve the quality of healthcare for billions of people. Invitae’s goal is to aggregate most of the world’s genetic tests into a single service with higher quality, faster turnaround time, and lower price than many single-gene and panel tests today. The company currently provides a diagnostic service comprising hundreds of genes for a variety of genetic disorders associated with oncology, cardiology, neurology, pediatrics, and other rare disease areas. For more information, visit our website at invitae.com.

Invitae CorporationLaura D’Angelo, 314-920-0617pr@invitae.com

1 Year Invitae Chart

1 Year Invitae Chart

1 Month Invitae Chart

1 Month Invitae Chart

Your Recent History

Delayed Upgrade Clock